Recruitment

Recruitment Status
Withdrawn
Estimated Enrollment
140

Summary

Conditions
Diabetes Mellitus - Type 2
Type
Interventional
Phase
Phase 4
Design
Allocation: RandomizedIntervention Model: Parallel AssignmentMasking: None (Open Label)Primary Purpose: Treatment

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

Not Provided

Not Provided

Tracking Information

NCT #
NCT01510522
Collaborators
Merck, S.L., Spain
Investigators
Study Director: Medical Responsible Merck, S.L., Spain